Firefly Neuroscience (NASDAQ:AIFF) and Intchains Group (NASDAQ:ICG) Critical Comparison

Firefly Neuroscience (NASDAQ:AIFF) and Intchains Group (NASDAQ:ICG) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Earnings and Valuation

This table compares Firefly Neuroscience and Intchains Group”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$110,000.00	128.77	-$10.46 million	($2.09)	-0.50
Intchains Group	$258.91 million	0.47	$7.05 million	$0.21	9.52

Intchains Group has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Intchains Group, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Volatility & Risk

Firefly Neuroscience has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Intchains Group has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Firefly Neuroscience and Intchains Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
Intchains Group	1	1	2	0	2.25

Intchains Group has a consensus target price of $7.50, suggesting a potential upside of 275.00%. Given Intchains Group’s stronger consensus rating and higher possible upside, analysts clearly believe Intchains Group is more favorable than Firefly Neuroscience.

Profitability

This table compares Firefly Neuroscience and Intchains Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-2,705.88%	-319.00%	-191.27%
Intchains Group	36.01%	8.98%	8.56%

Summary

Intchains Group beats Firefly Neuroscience on 10 of the 14 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Intchains Group

Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China.